Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1230
| Despition | MC3 Receptor Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1116 | Recombinant Human L1CAM Protein (6×His Tag) (AC1116) | 50 µg | inquiry |
| ACPP-1651 | Human AIDA Protein (AC1651) | 2 µg | inquiry |
| ACPP-1351 | Dopamine D2 Receptor Blocking Peptide (AC1351) | 250 µg | inquiry |
| ACPP-1217 | P2Y2 Blocking Peptide (AC1217) | 250 µg | inquiry |
| ACPP-1061 | Recombinant Human DLK-1 Protein (Fc Tag) (AC1061) | 50 µg | inquiry |
| ACPP-1284 | Nkx2.2 Blocking Peptide (AC1284) | 250 µg | inquiry |
| ACPP-1784 | Human GPI Protein (AC1784) | 5 µg | inquiry |
| ACPP-1387 | Human ARC Protein (AC1387) | 1 µg | inquiry |
| ACPP-1232 | GPCR GPR15 Blocking Peptide (AC1232) | 250 µg | inquiry |
| ACPP-1099 | Synthetic Nanodisc Human Adenosine Receptor A2a Protein (AC1099) | 10 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.